Physician profile
Victor Ferrans
NPI 1740345420
$3,654.96
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,424 · 2020: $910 · 2021: $1,077 · 2022: $245.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $1,462.00 | 2019-2022 | |
| Allergan, INC. | $779.63 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $357.77 | 2019-2021 | |
| Abbvie INC. | $293.54 | 2021 | |
| Neos Therapeutics, Lp | $165.61 | 2019 | |
| Tris Pharma INC | $105.57 | 2019 | |
| Bausch Health US, LLC | $100.00 | 2019 | |
| Orexo US, INC. | $90.17 | 2021 | |
| Shire North American Group INC | $90.08 | 2019 | |
| Ironshore Pharmaceuticals INC. | $47.80 | 2019 | |
| Arbor Pharmaceuticals, INC. | $44.96 | 2019 | |
| Lundbeck LLC | $44.49 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $32.01 | 2019 | |
| Supernus Pharmaceuticals, INC. | $23.85 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.48 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Ferrans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.